October 7, 2022
Tofacitinib Shows Promise in Scleroderma Patients, Researchers Are Optimistic for Next Phase of Study
Dinesh Khanna, MBBS, MSc and colleagues find that tofacitinib was well tolerated among patients with early systemic sclerosis in a phase I/II study.